SAN DIEGO, CA / ACCESSWIRE / March 7, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed in New Jersey for certain purchasers of shares of Novo Nordisk A/S (ADR) (NYSE: NVO) over alleged Securities Laws Violations by Novo Nordisk A/S.

Investors, who purchased shares of Novo Nordisk A/S (ADR) (NYSE: NVO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that Novo Nordisk A/S reported allegedly materially false and misleading earnings and forecasts in that they were inflated through the collusive price fixing of the Company's insulin drugs. The Complaint also alleges that Novo Nordisk A/S misrepresented and concealed the true extent of the pricing pressures it was experiencing from pharmacy benefit managers.

Those who purchased Novo Nordisk A/S (ADR) (NYSE: NVO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.